The CDC advisory committee voted Thursday to recommend that children ages 5 to 11 receive the Pfizer COVID-19 booster shot.
As previously reported by Human Events News, Pfizer announced on Tuesday that the FDA expanded its emergency use authorization of the vaccine to include children between the ages of 5 and 11. The Pfizer vaccine is currently the only one available for children under the age of 18.
With the CDC’s decision, immuno-compromised children will be eligible for four COVID-19 shots, Just the News reports. The CDC already recommended kids with immune problems to receive a third.
